Terms: = Ovarian cancer AND WRN, RECQL2, 7486, ENSG00000165392, Q14191, RECQ3 AND Treatment
5 results:
1. Germline cancer Gene Expression Quantitative Trait Loci Are Associated with Local and Global Tumor Mutations.
Liu Y; Gusev A; Kraft P
Cancer Res; 2023 Apr; 83(8):1191-1202. PubMed ID: 36745477
[TBL] [Abstract] [Full Text] [Related]
2. The wrn helicase: resolving a new target in microsatellite unstable cancers.
van Wietmarschen N; Nathan WJ; Nussenzweig A
Curr Opin Genet Dev; 2021 Dec; 71():34-38. PubMed ID: 34284257
[TBL] [Abstract] [Full Text] [Related]
3. Distinct roles of BRCA2 in replication fork protection in response to hydroxyurea and DNA interstrand cross-links.
Rickman KA; Noonan RJ; Lach FP; Sridhar S; Wang AT; Abhyankar A; Huang A; Kelly M; Auerbach AD; Smogorzewska A
Genes Dev; 2020 Jun; 34(11-12):832-846. PubMed ID: 32354836
[TBL] [Abstract] [Full Text] [Related]
4. The level of RECQL1 expression is a prognostic factor for epithelial ovarian cancer.
Matsushita Y; Yokoyama Y; Yoshida H; Osawa Y; Mizunuma M; Shigeto T; Futagami M; Imaizumi T; Mizunuma H
J Ovarian Res; 2014 Nov; 7():107. PubMed ID: 25424877
[TBL] [Abstract] [Full Text] [Related]
5. DNA-dependent protein kinase (DNA-PK)-dependent cisplatin-induced loss of nucleolar facilitator of chromatin transcription (FACT) and regulation of cisplatin sensitivity by DNA-PK and FACT.
Dejmek J; Iglehart JD; Lazaro JB
Mol Cancer Res; 2009 Apr; 7(4):581-91. PubMed ID: 19372586
[TBL] [Abstract] [Full Text] [Related]
